Amedeo's Top 20

Amedeo Smart

Independent Medical Education


09 September 2013

Multidisciplinary Journal Club

  1. Martinez FD , Vercelli D.
    Asthma.
    Lancet 2013.

  1. van der Meer AJ , Wedemeyer H, Feld JJ, Hansen BE, et al.
    Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
    J Hepatol 2013.

  2. Osinusi A , Meissner EG, Lee YJ, Bon D, et al.
    Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
    JAMA 2013;310:804-11.

  3. Sandborn WJ , Feagan BG, Rutgeerts P, Hanauer S, et al.
    Vedolizumab as induction and maintenance therapy for Crohn's disease.
    N Engl J Med 2013;369:711-21.

  4. Goss GD , O'Callaghan C, Lorimer I, Tsao MS, et al.
    Gefitinib Versus Placebo in Completely Resected Non-Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study.
    J Clin Oncol 2013.

  1. Hsu T , Ennis M, Hood N, Graham M, et al.
    Quality of Life in Long-Term Breast Cancer Survivors.
    J Clin Oncol 2013.

  2. Nagler A , Rocha V, Labopin M, Unal A, et al.
    Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen--A Report From the Acute %
    J Clin Oncol 2013.

  3. Bone HG , Chapurlat R, Brandi ML, Brown JP, et al.
    The Effect of 3 or 6 Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension.
    J Clin Endocrinol Metab 2013.

  4. Carlson JJ , Roth JA.
    The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
    Breast Cancer Res Treat 2013.

  5. Jess T , Horvath-Puho E, Fallingborg J, Rasmussen HH, et al.
    Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study.
    Am J Gastroenterol 2013.

  1. Hermans J , Luime JJ, Meuffels DE, Reijman M, et al.
    Does this patient with shoulder pain have rotator cuff disease?: The Rational Clinical Examination systematic review.
    JAMA 2013;310:837-47.

  2. von Minckwitz G , Mobus V, Schneeweiss A, Huober J, et al.
    German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer.
    J Clin Oncol 2013.

  3. Kawahara T , Nishikawa M, Kawahara C, Inazu T, et al.
    Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Circulation 2013;127:2327-35.

  4. Bjorck S , Palaszewski B, Friberg L, Bergfeldt L, et al.
    Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study.
    Stroke 2013.

  5. Morton LM , Dores GM, Curtis RE, Lynch CF, et al.
    Stomach Cancer Risk After Treatment for Hodgkin Lymphoma.
    J Clin Oncol 2013.

  1. Katritsis DG , Pokushalov E, Romanov A, Giazitzoglou E, et al.
    Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial.
    J Am Coll Cardiol 2013.

  2. Rieder F , Zimmermann EM, Remzi FH, Sandborn WJ, et al.
    Crohn's disease complicated by strictures: a systematic review.
    Gut 2013;62:1072-84.

  3. Garcia-Cabrera E , Fernandez-Hidalgo N, Almirante B, Ivanova-Georgieva R, et al.
    Neurologic Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study.
    Circulation 2013.

  4. Maggiori L , Goere D, Viana B, Tzanis D, et al.
    Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Ann Surg 2013;258:116-21.

  5. Murrough JW , Iosifescu DV, Chang LC, Al Jurdi RK, et al.
    Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial.
    Am J Psychiatry 2013.


more..


Privacy Policy